FCGR2A and Zika virus infectious disease: One type of MAb, such as MAb 4F10 and the MAbs described in other studies, is able to trigger FcγR-mediated phagocytosis but cannot inhibit ZIKV infection without effector cells (Fig. 3 and 4).